Regeneron Can't Escape Feds' Medicare Kickback Case
By Brian Dowling · December 4, 2020, 9:16 PM EST
Regeneron Pharmaceuticals Inc. must face claims that the millions of dollars it funneled to a patient-support charity were kickbacks meant to convince doctors to prescribe its pricey eye disease drug, a Massachusetts...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login